Cell & Gene
CARsgen Launches Clinical Trial in China for Innovative Allogeneic CAR T Therapy Targeting CD19/CD20
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
January 01, 2025 | News
CARsgen's Satricabtagene Autoleucel Achieves Positive Phase II Results in Advanced Gastric Cancer
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic mal...
December 31, 2024 | News
I Peace Achieves Milestone of Manufacturing 100 GMP-Grade iPS Cell Lines
Leading GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the n...
December 31, 2024 | News
New Therapeutics Venture GEMMABio Secures $34M in Seed Funding to Accelerate Gene Therapy Initiatives
Significant international investment defies sector trend GEMMA Biotherapeutics ("GEMMABio") – a new therapeutics company founded by gene therapy pio...
December 24, 2024 | News
YolTech Therapeutics Advances YOLT-201 Gene-Editing Therapy to Dose-Expansion Phase in ATTR Amyloidosis Clinical Trial
YolTech Therapeutics announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editin...
December 23, 2024 | News
SCG Cell Therapy Partners with A*STAR BTI and NATi to Accelerate RNA-Based Therapeutics Development and Commercialization
SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Ini...
December 23, 2024 | News
PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma
Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an addit...
December 20, 2024 | News
Nona Biosciences and Candid Therapeutics Collaborate to Advance Next-Generation T-Cell Engagers for Autoimmune Diseases
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced a research collaboration and lic...
December 17, 2024 | News
CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan
CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...
December 13, 2024 | News
SK pharmteco Unifies Global Brands to Establish CDMO Powerhouse
SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy indu...
December 12, 2024 | News
Thermo Fisher Enhances Cell Therapy Manufacturing with CTS Detachable Dynabeads™ for CD4+ and CD8+ T Cell Isolation
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing Thermo Fishe...
December 05, 2024 | News
South Korea’s S.BIOMEDICS Announces Promising Phase 1/2a Data for TED-A9 Cell Therapy in Parkinson’s Disease
-S.BIOMEDICS revealed promising one-year post-transplant data from their Phase 1/2a clinical trial of the TED-A9 cell therapy for Parkinson's disease....
November 27, 2024 | News
VectorBuilder and Sartorius Announce Strategic Partnership to Advance Gene Delivery and mRNA Bioprocess Solutions
VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopha...
November 27, 2024 | News
GenScript Biotech Hosts European Debut of Global Forum, Driving Collaboration in Cell and Gene Therapy Innovation
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenS...
November 22, 2024 | Report
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
